Starch is a major energy source for all domains of life. Recent advances in structures of starch-degrading enzymes encompass the substrate complex of starch debranching enzyme, the function of surface binding sites in plant isoamylase, details on individual steps in the mechanism of plant disproportionating enzyme and a self-stabilised conformation of amylose accommodated in the active site of plant a-glucosidase.
Introduction
Starch is the most abundant storage polyglucan in nature serving as energy source for all domains of life. Accordingly starch degrading enzymes occur ubiquitously in plants, other eukaryotes, bacteria and archaea (see the carbohydrate-active enzymes database, CAZy; [1] ). During the biosynthesis starch is deposited as supramolecular, semicrystalline granules basically consisting of two a-glucans, the branched amylopectin and the essentially linear amylose (see [2] for a recent review on starch). In plants starch can be either a transitory energy and building block supply synthesised and degraded in the diurnal cycle in leaves or a long-term storage residing in grains and tubers.
Starch is a simple polymer of α-1,4-and α-1,6-linked glucose residues, yet a multiplicity of enzyme activities is required for degradation of the complex starch granules as well as amylose and amylopectin alone (Figure 1 ). Starch-degrading enzymes include glycoside hydrolases (GHs), transglycosidases, glycosyl transferases (GTs) (phosphorylases), lyases, phosphatases and lytic polysaccharide monooxygenases (LPMOs). Here emphasis is on enzymes naturally involved in starch degradation, thus bacterial intracellular enzymes acting on glycogen are excluded although they degrade starch. Focus is on structures of new enzyme-types, new structures for previously characterized enzymes, and enzyme complexes with substrates, substrate analogues, natural products, and proteinaceous inhibitors. Starch-degrading enzymes according to CAZy [1] are found in GH families 3, 13, 14, 15, 31, 57, 119, eventually 126, auxiliary activities (AA) family 13 and GT family 35. a-amylases, a-glucosidases, limit dextrinases/pullulanases, isoamylases, lytic polysaccharide monooxygenases, disproportionating enzymes, and starch phosphorylases will be explicitly addressed (see Table 1 for a complete overview). a-glucan phosphatase is reviewed elsewhere in this issue [3] .
The mentioned enzymes differ in catalytic domain fold, catalytic mechanism, and modular architecture encompassing auxiliary domains, primarily functionally and structurally discrete noncatalytic carbohydrate binding modules (CBMs) ( Figure 2 ). Enzymes of the same family, e.g. GH13, can possess differently shaped active sites; i) a single shallow cleft spanning from a few to more than 10 glucosyl residues accommodating subsites for linear substrates in endo-acting αamylases; ii) a pocket shaped binding site extending in exo-glucanases and glucosidases from a catalytic site in a deep cavity and composed of two to several subsites; or iii) in debranching enzymes two interconnected shallow clefts running in parallel.
Many of these multi-domain enzymes also contain dedicated carbohydrate binding sites that are situated outside of the active site area as seen for example on CBMs. Starch binding CBMs are organised in 12 families (CBM 20, 21, 25, 26, 34, 41, 45, 48, 53, 58, 68, 69 ; [1] ). In silico "domainwalking" using a predicted CBM may disclose starch-active catalytic domains in full length sequences as in case of LPMOs in family AA13 [4] for which a crystal structure was recently solved [5] . Carbohydrate binding areas are also identified in form of surface surface binding sites (SBSs) situated on catalytic or intimately associated domains (Figure 2 ). Identification and functional characterisation of SBSs typically start with its observation in an enzyme:carbohydrate complex [6] . SBSs are difficult to predict even though several starch-active enzymes contain SBSs with validated roles in activity [7] . Recently, SBSs were also characterised in starch synthase I [8, 9] and in glycogen synthase [10, 11] , where they ensure enzyme proximity to the a-glucan molecule during its elongation. SBSs have also been identified in a-glucan phosphatases (reviewed in [3] ).
α-amylases
According to CAZy, α-amylase (EC 3.2.1.1), probably the best studied amylolytic enzyme, is found in GH13, GH57, GH119, and GH126 (α-amylase activity not fully confirmed) [1, 12] . Eleven GH13 subfamilies contain α-amylases: GH13_1 (fungi), GH13_5 (bacterial liquefying enzymes), GH13_6 (plants), GH13_7 (archaea), GH13_15 (insects), GH13_24 (animals), GH13_27 (proteobacteria), GH13_28 (bacterial saccharifying enzymes), GH13_32 (bacteria), GH13_36 (intermediary αamylase group evolutionary found between oligo-1,6-glucosidases and neopullulanases), GH13_37 (marine bacteria), and GH13_41 (starch degrading enzymes with both an α-amylase and a pullulanase domain [13]) [12, 14] . Twenty-three different α-amylases are structure-determined including enzymes from GH13_5, GH13_6, and GH57 published recently [1, [15] [16] [17] . The industrial 
Starch debranching enzymes; limit dextrinase, pullulanases and isoamylases
Plant limit dextrinases and the closely related bacterial type I pullulanases hydrolysing a-1,6linkages in pullulan, amylopectin and branched maltooligosaccharides (limit dextrins, hence the enzyme name) belong to subfamily GH13_13 with bacterial pullulanases, also found in GH13_12 and GH13_14, while isoamylases are in subfamily GH13_11. In addition to the classical pullulanase type I debranching enzymes, some organisms have type II pullulanases, which hydrolyze both a-1,4and a-1,6-linkages in starch. This activity occurs in GH13 and GH57, but no A structure was also solved recently of Arabidopsis a-1,4-glucan phosphorylase AtPHS2 (PDB: 4BQE) that succeeds DPE1 in the degradation pathway [56] and structurally resembles the wellstudied orthologue glycogen phosphorylase (GP) for which allosteric and covalent control were described [57, 58] . Remotely relative to the active site AtPHS2 has maltotriose bound at a characteristic SBS not seen in GP, which is situated adjacent to and almost contiguous with the maltopentaose binding site of GP (PDB: 1P29). AtPHS2 is a biologically relevant dimer showing no interaction equivalent to GP with an allosteric activator and has a more open active site that may explain the lack of allosteric regulation [56].
Inhibitors of starch modifying enzymes
Human salivary (HSA) and pancreatic a-amylases (HPA), associated with carbohydrate uptake and thereby with diseases like diabetes and metabolic syndrome, are key inhibitor discovery targets [59, 60] . A large number of structures are available of these enzymes, HPA first solved in 1995 (PDB: 1HNY) [61] and HSA in 1996 (PDB: 1SMD) [62] . Recently, a structure was determined of HPA in complex with the potent and specific inhibitor montbretin A (PDB: 4W93) (Figure 3a ), a plant flavonol glycoside with potential in diabetes and obesity therapies [59] . Montbretin A applies a novel interaction mode where its two phenolic groups, myricetin and caffeic acid, are preorganised via hydrophobic stacking to optimize hydrogen bonding with the catalytic carboxyl groups (Figure 3a) . The phenolic moieties are linked through a largely non-interacting disaccharide and a combination of structural studies and degradation analysis led to design of a simplified analogue in which they are connected via an alkyl chain [59] . Another structure of an HPA inhibitor was published in the beginning of 2016 (PDB: 4X0N). A high-throughput screen of marine natural product extracts identified a potent (K i =10 pM) peptidic inhibitor, helianthamide. However, a complex of the inhibitor was only obtained with porcine pancreatic a-amylase ( Figure 3b ) that has high sequence and structural homology to HPA. Helianthamide belongs to a group of antimicrobial peptides adopting a β-defensin fold and binds into and across the amylase active site (Figure 3b ) [60] showing the first structure of a novel class of glycosidase inhibitors.
Control of starch degrading enzymes is also highly relevant for other organisms. Thus some plants use inhibitors in defence against pests as seen by the structure of a cereal-type inhibitor RBI (Ragi bifunctional a-amylase/trypsin inhibitor) in complex with an insect a-amylase from yellow mealworm (Tenebrio molitor) (PDB: 1TMQ) [63] . The barley LD is regulated by an endogenous limit dextrinase inhibitor (LDI) with picomolar affinity and the LD:LDI structure was solved recently (PDB: 4CVW; Figure 3c ) [64] . LDI is also a cereal-type inhibitor, but with a role in controlling LD activity rather than in pest defence [64] . Remarkably, although LDI belongs to the cereal-type inihibitor family it uses a fundamentally different orientation in binding (Figure 3d ) and has a unique motif that stabilizes the enzyme complex through an intermolecular hydrophobic cluster (Figure 3c ). The LDI and helianthamide enzyme complexes add to the five previously described modes of proteinaceous inhibitor GH13 starch-hydrolase interactions [65] .
Conclusions
New details on functional structural elements add to understanding of mechanism of action and specificity of enzymes participating in starch-degradation. Notable advances concern complexes containing branched or long oligosaccharide substrates/inhibitory substrate analogues enlightening enzyme structural elements engaged in macromolecular substrate interactions. Overall new structural facets offer targets for innovative protein engineering exploiting and unravelling relationships between structure and function in the enzyme-substrate/inhibitor interplays.
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